Background: HBV infection is a major problem worldwide, especially in developing countries including Indonesia. Mutations in the HBV gene X are commonly found in patients with CLD, especially in cirrhosis and hepatocellular carcinoma. Mutations in the X gene can cause loss of stability, increased transactivation function, and decreased anti-apoptotic ability of HBx protein. Aim: The aim of this study was to detect HBV X gene mutations in CLD patients in Surabaya. Methods: This was a cross sectional research taking samples at Dr. Soetomo General Hospital, Surabaya, Indonesia. This study used nested PCR by targeting HBV X gene. Samples showing positive HBV DNA PCR results were followed by sequencing and X gene mutation analysis by comparing...
INTRODUCTION: Specific mutations in Hepatitis-B Virus (HBV) genome would proceed the development of ...
Aims: The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B ...
Resistance to anti-viral drugs is a global problem in the treatment of HBV. Around 350 million peopl...
Background: HBV infection is a major problem worldwide, especially in developing countries including...
Infection of hepatitis B virus (HBV) is a global health problem, including in Indonesia. There are ...
Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and it infects hepatocytes, which is th...
Abstract Background and objective: Hepatitis B virus (HBV) is a DNA virus with high tendency ...
Background: Hepatitis B Virus (HBV) infection is a major public health problem. Approximately, more ...
Introduction: Specific mutations in Hepatitis-B Virus (HBV) genome would proceed the development of ...
Infection by hepatitis B virus (HBV) is a worldwide public health problem. Chronic HBV infection wit...
Introduction: Chronic hepatitis B (CHB) has been considered a global health problem for years. Diffe...
Introduction: HBx is a multifunctional modulator viral protein with key roles in various biological ...
Background: Hepatitis B infection is one of the most common infection in the world which has a very ...
AIMS: The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B ...
Objective The purpose of this study was to complete the data frequency and mutation profile of Hepat...
INTRODUCTION: Specific mutations in Hepatitis-B Virus (HBV) genome would proceed the development of ...
Aims: The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B ...
Resistance to anti-viral drugs is a global problem in the treatment of HBV. Around 350 million peopl...
Background: HBV infection is a major problem worldwide, especially in developing countries including...
Infection of hepatitis B virus (HBV) is a global health problem, including in Indonesia. There are ...
Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and it infects hepatocytes, which is th...
Abstract Background and objective: Hepatitis B virus (HBV) is a DNA virus with high tendency ...
Background: Hepatitis B Virus (HBV) infection is a major public health problem. Approximately, more ...
Introduction: Specific mutations in Hepatitis-B Virus (HBV) genome would proceed the development of ...
Infection by hepatitis B virus (HBV) is a worldwide public health problem. Chronic HBV infection wit...
Introduction: Chronic hepatitis B (CHB) has been considered a global health problem for years. Diffe...
Introduction: HBx is a multifunctional modulator viral protein with key roles in various biological ...
Background: Hepatitis B infection is one of the most common infection in the world which has a very ...
AIMS: The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B ...
Objective The purpose of this study was to complete the data frequency and mutation profile of Hepat...
INTRODUCTION: Specific mutations in Hepatitis-B Virus (HBV) genome would proceed the development of ...
Aims: The aim of this study was to investigate the genomic mutations in the circulating Hepatitis B ...
Resistance to anti-viral drugs is a global problem in the treatment of HBV. Around 350 million peopl...